| Literature DB >> 30959520 |
David A Lindholm1,2, Raymond D Fisher2, Jay R Montgomery3, Whitni Davidson4, Patricia A Yu5, Yon C Yu5, Jillybeth Burgado4, Kimberly Wilkins4, Brett W Petersen4, Jason F Okulicz1,2.
Abstract
Smallpox vaccine is contraindicated in immunosuppression due to increased risk for adverse reactions (eg, progressive vaccinia). We describe the first-ever use of tecovirimat as a preemptive vaccinia virus treatment strategy during induction chemotherapy in an active duty service member who presented with acute leukemia and inadvertent autoinoculation after smallpox vaccination. Published by Oxford University Press for the Infectious Diseases Society of America 2019.Entities:
Keywords: ST-246; leukemia; smallpox vaccine; tecovirimat; vaccinia
Mesh:
Substances:
Year: 2019 PMID: 30959520 DOI: 10.1093/cid/ciz286
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 20.999